A Phase 2 Open-label, Dose Escalation Study of HST5040 in Subjects with Propionic or Methylmalonic Acidemia Followed by a 6-Month, Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study and an Open-label, Long-term Extension Study
2023-03-06
عنوان الدراسة
A Phase 2 Open-label, Dose Escalation Study of HST5040 in Subjects with Propionic or Methylmalonic Acidemia Followed by a 6-Month, Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study and an Open-label, Long-term Extension Study
داعم الدراسة
HemoShear Therapeutics,
دواء الدراسة
ST5040 (2,2-dimethylbutanoic acid)
رقم بروتوكول الدراسة
HST20-CL01
حالة الدراسة
Terminated
موقع الدراسة
King Faisal Specialist Hospital and Research Center (Riyadh)
مرحلة الدراسة
4
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.